Tianjin Medical University Cancer Institute and Hospital: Stomach Neoplasms trials

The registry lists 32 Stomach Neoplasms studies with Tianjin Medical University Cancer Institute and Hospital as lead sponsor. 13 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 11Phase 3 2Phase 4 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Laparoscopic Staging for Stage III Gastric CancerEnrolling by invitationNCT07533825Not applicable
• The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric CancerRecruitingNCT07183150
• Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 OverexpressionRecruitingNCT06560528Phase 2
• Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric CancerNot yet recruitingNCT06454435Phase 2
• Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsRecruitingNCT06383559Phase 2
• Fruquintinib Combined With TAS102 for Advanced Gastric CancerRecruitingNCT06102785
• Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric CancerRecruitingNCT06102772
• Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody FailedRecruitingNCT06102759
• The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric CancerRecruitingNCT06033482
• Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ CancerRecruitingNCT05853172Phase 2
• A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric CancerRecruitingNCT04843215Not applicable
• A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in GastrectomyRecruitingNCT04108494Not applicable
• XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring CarcinomaNot yet recruitingNCT03355612Phase 3
• A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal MalignanciesActive, not recruitingNCT06997302Not applicable
• A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC PatientsCompletedNCT06339307
• A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative SurgeryCompletedNCT06023966
• Disitamab Vedotin Combined With Sintilimab as First-line Treatment of Elderly Patients With Gastric CancerStatus unknownNCT05720533Phase 2
• Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric CancerStatus unknownNCT05627414Phase 2
• Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric CancerStatus unknownNCT05228743Not applicable
• Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsStatus unknownNCT05221775Phase 1
• Chemotherapy Combined With Apatinib and PD-1 AntibodyCompletedNCT05025033Phase 2
• Peri-operative Sintilimab in Combination With SOX in Locally Advanced Gastric CancerStatus unknownNCT04982939Phase 2
• Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y ReconstructionStatus unknownNCT04801459Not applicable
• Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric CancerCompletedNCT04354662Phase 2
• Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric CancerActive, not recruitingNCT04267549Phase 2
• The Criteria for Lymph Node Sorting for Pathological Examination in Gastric CancerStatus unknownNCT03478449Not applicable
• A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant ChemotherapyStatus unknownNCT02776527Phase 4
• A Trial to Evaluate the Superior Mesenteric Vein (14V) Lymphadenectomy for Distal Advanced Gastric CancerStatus unknownNCT02272894
• Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric CancerStatus unknownNCT02024438Phase 3
• Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric CancerStatus unknownNCT01637805Phase 1
• Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 DiabetesStatus unknownNCT01637350
• Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer PatientsStatus unknownNCT01618474Phase 2